{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T11:29:18Z","timestamp":1793878158280,"version":"4.7.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1845298"],"award-info":[{"award-number":["1845298"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET-2145491"],"award-info":[{"award-number":["CBET-2145491"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["T90DE030854"],"award-info":[{"award-number":["T90DE030854"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2TR002776"],"award-info":[{"award-number":["DP2TR002776"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jconrel.2024.05.036","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T03:04:31Z","timestamp":1717988671000},"page":"455-469","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta"],"prefix":"10.1016","volume":"371","author":[{"given":"Hannah C.","family":"Geisler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi A.","family":"Ghalsasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Safford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Swingle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay S.","family":"Thatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin J.","family":"Mukalel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningqiang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex G.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin E.","family":"Nachod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall S.","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.05.036_bb0005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0010","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","article-title":"Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines","volume":"27","author":"Swingle","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0015","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nbt0918-777","article-title":"Alnylam launches era of RNAi drugs","volume":"36","author":"Garber","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002105","article-title":"Biotechnology: overcoming biological barriers to nucleic acid delivery using lipid nanoparticles","volume":"21","author":"Hamilton","year":"2023","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0030","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2017.56","article-title":"Tools for translation: non-viral materials for therapeutic mRNA delivery","volume":"2","author":"Hajj","year":"2017","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0040","first-page":"1449","article-title":"Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver, biomaterials","volume":"9","author":"Zhang","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0045","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/mt.2008.127","article-title":"Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers","volume":"16","author":"Muro","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0055","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0070","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1021\/jacs.8b08976","article-title":"Nanoparticles that deliver RNA to bone marrow identified by in vivo directed evolution","volume":"140","author":"Sago","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0075","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1021\/jacs.2c12893","article-title":"Ionizable lipid nanoparticles for in vivo mRNA delivery to the placenta during pregnancy","volume":"145","author":"Swingle","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0080","article-title":"Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta","volume":"2303568","author":"Safford","year":"2023","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0085","article-title":"Lipid nanoparticle composition drives mRNA delivery to the","author":"Young","year":"2022","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0090","series-title":"Lipid nanoparticle structure and delivery route during pregnancy dictates mRNA potency, immunogenicity, and health in the mother and offspring","author":"Chaudhary","year":"2023"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0095","doi-asserted-by":"crossref","first-page":"2300852","DOI":"10.1002\/smll.202300852","article-title":"Rational Design of Nanomedicine for placental disorders: birthing a new era in Women's reproductive health","author":"Geisler","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0100","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/sper.2001.24565","article-title":"Physiologic changes in pregnancy and their effect on drug disposition","volume":"25","author":"Frederiksen","year":"2001","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0105","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.mam.2012.12.008","article-title":"Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia","volume":"34","author":"Ji","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0110","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00018-019-03104-6","article-title":"Human placenta and trophoblast development: key molecular mechanisms and model systems","volume":"76","author":"Kn\u00f6fler","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.addr.2020.09.006","article-title":"Exploiting the placenta for nanoparticle-mediated drug delivery during pregnancy","volume":"160","author":"Figueroa-Espada","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0125","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0040-1712103","article-title":"Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: a review of international registries","volume":"37","author":"Smith","year":"2020","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.addr.2020.09.013","article-title":"Diseases and conditions that impact maternal and fetal health and the potential for nanomedicine therapies","volume":"170","author":"Nelson","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0135","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s44222-023-00040-w","article-title":"Delivery technologies for women's health applications","volume":"1","author":"Swingle","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10404-012-1024-5","article-title":"The influence of size, shape and vessel geometry on nanoparticle distribution","volume":"14","author":"Tan","year":"2013","journal-title":"Microfluid. Nanofluid."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0150","doi-asserted-by":"crossref","first-page":"34710","DOI":"10.1038\/srep34710","article-title":"Uterus-targeted liposomes for preterm labor management: studies in pregnant mice","volume":"6","author":"Refuerzo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0155","series-title":"Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke","author":"Nong","year":"2023"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0160","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.7150\/thno.19678","article-title":"Selective targeting of a novel vasodilator to the uterine vasculature to treat impaired Uteroplacental perfusion in pregnancy","volume":"7","author":"Cureton","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0165","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.biopha.2018.08.042","article-title":"EGFR aptamer-conjugated liposome-polycation-DNA complex for targeted delivery of SATB1 small interfering RNA to choriocarcinoma cells","volume":"107","author":"Dong","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0170","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/09687688.2010.521200","article-title":"Receptor-targeted nanocarriers for therapeutic delivery to cancer","volume":"27","author":"Yu","year":"2010","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/smll.201502730","article-title":"Dose-dependent therapeutic distinction between active and passive targeting revealed using transferrin-coated PGMA nanoparticles","volume":"12","author":"Singh","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0180","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1021\/acs.nanolett.3c00304","article-title":"In vivo RNA delivery to hematopoietic stem and progenitor cells via targeted lipid nanoparticles","volume":"23","author":"Shi","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0185","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.10.015","article-title":"PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake","volume":"291","author":"Parhiz","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0195","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2018.03.002","article-title":"Insights into maleimide-thiol conjugation chemistry: conditions for efficient surface functionalization of nanoparticles for receptor targeting","volume":"282","author":"Mart\u00ednez-Jothar","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","article-title":"Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies","volume":"320","author":"Marques","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0205","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrd.2016.268","article-title":"Strategies and challenges for the next generation of antibody\u2013drug conjugates","volume":"16","author":"Beck","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0210","first-page":"eabc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy, science","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Advances"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0215","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1038\/s41467-018-06936-1","article-title":"Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes","volume":"9","author":"Veiga","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41565-017-0043-5","article-title":"A modular platform for targeted RNAi therapeutics","volume":"13","author":"Kedmi","year":"2018","journal-title":"Nat. Nanotech."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0225","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1021\/acs.bioconjchem.8b00319","article-title":"Targeting Protumoral tumor-associated macrophages with Nanobody-functionalized Nanogels through strain promoted Azide alkyne cycloaddition ligation","volume":"29","author":"Nuhn","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106982","article-title":"Click chemistry in the synthesis of antibody-drug conjugates","volume":"143","author":"Dudchak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0235","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0240","doi-asserted-by":"crossref","DOI":"10.1530\/JME-22-0105","article-title":"The epidermal growth factor receptor in healthy pregnancy and preeclampsia","volume":"70","author":"Clemente","year":"2023","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0245","first-page":"1897","article-title":"In vitro fertilization and embryo transfer alter human placental function through trophoblasts in early pregnancy","volume":"21","author":"Zhao","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0250","doi-asserted-by":"crossref","first-page":"e60266","DOI":"10.7554\/eLife.60266","article-title":"Single nuclei RNA-seq of mouse placental labyrinth development","volume":"9","author":"Marsh","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0255","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.118.12300","article-title":"EGFR (epidermal growth factor receptor) signaling and the mitochondria regulate sFlt-1 (soluble FMS-like tyrosine Kinase-1) secretion","volume":"73","author":"Hastie","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0260","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1021\/ja301621z","article-title":"Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation","volume":"134","author":"Chen","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1039\/C7SC02747H","article-title":"Forming next-generation antibody\u2013nanoparticle conjugates through the oriented installation of non-engineered antibody fragments","volume":"9","author":"Greene","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0270","first-page":"194","article-title":"Effect of ligand density, receptor density, and nanoparticle size on cell targeting, nanomedicine: nanotechnology","volume":"9","author":"Elias","year":"2013","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0275","doi-asserted-by":"crossref","first-page":"8158","DOI":"10.1021\/ac501536z","article-title":"How antibody surface coverage on nanoparticles determines the activity and kinetics of antigen capturing for biosensing","volume":"86","author":"Saha","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0280","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antib8010024","article-title":"IgG charge: practical and biological implications","volume":"8","author":"Yang","year":"2019","journal-title":"Antibodies (Basel)"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0285","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10616-017-0142-z","article-title":"Co-culture of JEG-3, BeWo and syncBeWo cell lines with adrenal H295R cell line: an alternative model for examining endocrine and metabolic properties of the fetoplacental unit","volume":"70","author":"Drwal","year":"2018","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0290","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1021\/acsnano.1c08277","article-title":"A single-molecule view at nanoparticle targeting selectivity: correlating ligand functionality and cell receptor density","volume":"16","author":"Woythe","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0295","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.celrep.2017.04.048","article-title":"A chimeric Egfr protein reporter mouse reveals Egfr localization and trafficking in vivo","volume":"19","author":"Yang","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0300","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.placenta.2007.07.005","article-title":"Altered trophoblast proliferation is insufficient to account for placental dysfunction in Egfr null embryos","volume":"28","author":"Dackor","year":"2007","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0305","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/ijms18061249","article-title":"Emerging role of the spleen in the pharmacokinetics of monoclonal antibodies, nanoparticles and exosomes","volume":"18","author":"Cataldi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0310","doi-asserted-by":"crossref","first-page":"24045","DOI":"10.1038\/s41598-021-03196-w","article-title":"A functional spleen contributes to afucosylated IgG in humans","volume":"11","author":"Wojcik","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0315","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1080\/19420862.2017.1337619","article-title":"Quantification of IgG monoclonal antibody clearance in tissues","volume":"9","author":"Eigenmann","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0320","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrendo.2010.46","article-title":"Immunity, thyroid function and pregnancy: molecular mechanisms","volume":"6","author":"Weetman","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0325","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00335-009-9189-2","article-title":"Placental overgrowth and fertility defects in mice with a hypermorphic allele of epidermal growth factor receptor","volume":"20","author":"Dackor","year":"2009","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0330","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","article-title":"A direct comparison of in vitro and in vivo nucleic acid delivery mediated by hundreds of nanoparticles reveals a weak correlation","volume":"18","author":"Paunovska","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0335","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/jphp.13098","article-title":"An overview of active and passive targeting strategies to improve the nanocarriers efficiency to tumour sites","volume":"71","author":"Attia","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0340","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0350","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/acs.nanolett.6b03329","article-title":"Lipid nanoparticle assisted mRNA delivery for potent Cancer immunotherapy","volume":"17","author":"Oberli","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0355","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.biomaterials.2016.09.006","article-title":"Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo","volume":"109","author":"Kauffman","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0360","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1038\/ncomms5277","article-title":"Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity","volume":"5","author":"Whitehead","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0365","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1182\/blood.V78.4.885.885","article-title":"Neutrophils express the high affinity receptor for IgG (Fc\u03b3RI, CD64) after in vivo application of recombinant human granulocyte Colony-stimulating factor","volume":"78","author":"Repp","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0370","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.122.317963","article-title":"New approaches for targeting PCSK9: small-interfering ribonucleic acid and genome editing","volume":"43","author":"Oostveen","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0375","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3389\/fimmu.2019.02317","article-title":"Dynamic function and composition changes of immune cells during Normal and pathological pregnancy at the maternal-fetal Interface","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0380","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.7150\/thno.25228","article-title":"Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles","volume":"8","author":"Johnsen","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2024.05.036_bb0385","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","article-title":"Cancer active targeting by nanoparticles: a comprehensive review of literature","volume":"141","author":"Bazak","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2024.05.036_bb0390","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:43:35Z","timestamp":1777509815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":78,"alternative-id":["S0168365924003201"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}